Curia Overview
- Year Founded
-
1991
- Status
-
Private
- Employees
-
3,500
- Latest Deal Type
-
Debt
- Financing Rounds
-
25
- Investments
-
19
Curia General Information
Description
Provider of contract research and manufacturing services intended to improve patient outcomes and the quality of life. The company offers drug discovery solutions, drug development solutions, analytical services and manufacturing solutions to pharmaceutical and biotechnology industries, enabling them to solve complex scientific challenges to make patients' lives better.
Contact Information
Website
curiaglobal.comCorporate Office
- 26 Corporate Circle
- Albany, NY 12203
- United States
Corporate Office
- 26 Corporate Circle
- Albany, NY 12203
- United States
Curia Timeline
Curia Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Curia Comparisons
Industry
Financing
Details
000000
000000
Curia Competitors (36)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aragen Life Sciences | Private Equity-Backed | Hyderabad, India | 0000 | 0000 | 00000000000 | 0000 |
| Parexel International | Private Equity-Backed | Durham, NC | 00000 | 00.000 | 000000000 00 | 00.000 |
| Almac Group | Corporation | Craigavon, United Kingdom | 0000 | 0000000000 | ||
| Cromsource | Corporate Backed or Acquired | Verona, Italy | 000 | 000000&0 | ||
| Rho | Corporation | Chapel Hill, NC | 000 | 0000000000 |
Curia Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Curia Patents
Curia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230105412-A1 | 5-ht3 receptor modulator, the crystalline form, methods of making, and use thereof | Pending | 16-Mar-2020 | 0000000000 | |
| US-20230135152-A1 | Pikfyve kinase inhibitors | Pending | 11-Feb-2020 | 000000000 | |
| US-20230404939-A1 | Solid forms of cannabidiol and uses thereof | Pending | 11-Dec-2017 | 000000000 | |
| US-20190177258-A1 | New solid forms of cannabidiol and uses thereof | Inactive | 11-Dec-2017 | 000000000 | |
| US-11364202-B2 | Solid forms of cannabidiol and uses thereof | Active | 11-Dec-2017 | C07C39/23 | 00 |
Curia Executive Team (23)
| Name | Title | Board Seat |
|---|---|---|
| Philip Macnabb | Chief Executive Officer | |
| Gerald Auer | Chief Financial Officer | |
| Joseph Sangregorio | Chief Human Resources Officer | |
| Prakash Pandian | Chief Information Officer | |
| James Grabowski Ph.D | Vice President, Business Unit Operations - API |
Curia Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000 | Self | Board Member | 000 0000 |
| 0000 00000000 | Self | Board Member | 000 0000 |
Curia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Curia Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Curia Investments & Acquisitions (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LakePharma | 02-Sep-2021 | 0000000000 | Biotechnology | 0000 0000 | |
| Integrity Bio | 04-Aug-2021 | 0000000000 | Biotechnology | 0000 0000 | |
| Archimica | 11-Jul-2016 | 0000000000 | 00000 | Pharmaceuticals | 0000000 0 |
| Archimica (Chemical Manufacturing Facilities) | 05-May-2016 | 000000000 | Buildings and Property | ||
| Whitehouse Laboratories | 15-Dec-2015 | Merger/Acquisition | 0000 | BPO/Outsource Services | 0000000 0 |
Curia ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Laboratory Equipment and Services
Subindustry
Rank
Percentile
Curia FAQs
-
When was Curia founded?
Curia was founded in 1991.
-
Who is the founder of Curia?
Thomas D'Ambra Ph.D and Chester Opalka are the founders of Curia.
-
Who is the CEO of Curia?
Philip Macnabb is the CEO of Curia.
-
Where is Curia headquartered?
Curia is headquartered in Albany, NY.
-
What is the size of Curia?
Curia has 3,500 total employees.
-
What industry is Curia in?
Curia’s primary industry is Biotechnology.
-
Is Curia a private or public company?
Curia is a Private company.
-
What is Curia’s current revenue?
The current revenue for Curia is 00000.
-
How much funding has Curia raised over time?
Curia has raised $265M.
-
Who are Curia’s investors?
GTCR, HarbourVest Partners, The Carlyle Group, and Auburn Hill Capital have invested in Curia.
-
Who are Curia’s competitors?
Aragen Life Sciences, Parexel International, Almac Group, Cromsource, and Rho are some of the 36 competitors of Curia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
